Last Update

This profile was last updated on 5/19/2017 and contains contributions from the  ZoomInfo Community.

is this you? Claim your profile.

Wrong Doug Plessinger?

Doug Plessinger

Vice President, Medical and Clinical Affairs

Aprecia Pharmaceuticals Company

HQ Phone:  (215) 359-3300

Direct Phone: (513) ***-****direct phone

Email: d***@***.com

Get Zoominfo Grow
Community Edition

+ Get 10 Free Contacts a Month

Please agree to the terms and conditions.

I agree to the  Terms of Service and  Privacy Policy. I understand that I will receive a subscription to ZoomInfo Community Edition at no charge in exchange for downloading and installing the ZoomInfo Contact Contributor utility which, among other features, involves sharing my business contacts as well as headers and signature blocks from emails that I receive.

THANK YOU FOR DOWNLOADING!

computers
  • 1.Download
    the Plugin
    v sign
  • 2.Run Installation
    Wizard
  • 3.Check Your Inbox to
    Sign Up for ZoomInfo Community Edition

I agree to the Terms of Service and Privacy Policy. I understand that I will receive a subscription to ZoomInfo Community Edition at no charge in exchange for downloading and installing the ZoomInfo Contact Contributor utility which, among other features, involves sharing my business contacts as well as headers and signature blocks from emails that I receive.

Aprecia Pharmaceuticals Company

2010 Cabot Boulevard West Suite F

Langhorne, Pennsylvania, 19047

United States

Company Description

Aprecia is a commercial stage pharmaceutical company developing, manufacturing and marketing fast melt formulations of high dose pharmaceuticals, initially focused on epilepsy and other central nervous system disorders. Aprecia manufactures its products using ...more

Find other employees at this company (83)

Background Information

Employment History

Executive Vice President, Managing Director

Axcelo MSL Solutions, LLC


Principal, Managing Partner

venn5 BioConsulting LLC


Affiliations

Argos Therapeutics Inc

Vice President, Clinical and Medical Affairs


Millennium Pharmaceuticals , Inc.

Oncology Medical Science Liaison


Education

B.S.

pharmacy

Northeastern University


Web References(26 Total References)


http://www.thepmd.com/newsletter/pharmaceutical-marketers-directory-newsletter-2016-june.aspx

Doug Plessinger, Aprecia Pharmaceuticals Company, VP, Medical & Clinical Affairs


Management – Argos Therapeutics

Douglas Plessinger RPh Vice President, Clinical and Medical Affairs
Douglas C. Plessinger, RPh, joined as our Vice President of Clinical and Medical Affairs effective October 2011, after serving as a clinical consultant for Argos since October 2007. Prior to joining us, Mr. Plessinger served as Executive Vice President and Managing Director at Axcelo MSL Solutions, LLC, an oncology consulting company, from August 2008 to September 2011 and founding partner and Managing Director of its predecessor company, venn5 BioConsulting, LLC, from 2007 to 2008. Prior to this, he served as Senior Vice President, Account Services at The Navicor Group, LLC, a healthcare advertising agency and a division of inVentiv Health, Inc., a healthcare services company, from 2004 to 2007; Oncology Medical Science Liaison at Millennium Pharmaceuticals, Inc., from 2002 to 2003; and in various Medical Affairs and Product Development roles at Bristol-Myers Squibb Oncology, a pharmaceutical company, from 1997 to 2002. Mr. Plessinger received a B.S. in pharmacy from Northeastern University.


Argos Therapeutics – Leadership

Doug Plessinger, RPh Vice President, Clinical and Medical Affairs
Douglas C. Plessinger, RPh, joined as our Vice President of Clinical and Medical Affairs effective October 2011, after serving as a clinical consultant for Argos since October 2007. Prior to joining us, Mr. Plessinger served as Executive Vice President and Managing Director at Axcelo MSL Solutions, LLC, an oncology consulting company, from August 2008 to September 2011 and founding partner and Managing Director of its predecessor company, venn5 BioConsulting, LLC, from 2007 to 2008. Prior to this, he served as Senior Vice President, Account Services at The Navicor Group, LLC, a healthcare advertising agency and a division of inVentiv Health, Inc., a healthcare services company, from 2004 to 2007; Oncology Medical Science Liaison at Millennium Pharmaceuticals, Inc., from 2002 to 2003; and in various Medical Affairs and Product Development roles at Bristol-Myers Squibb Oncology, a pharmaceutical company, from 1997 to 2002. Mr. Plessinger received a B.S. in pharmacy from Northeastern University.


Argos Therapeutics Management Team

Doug Plessinger, RPh
Vice President, Clinical and Medical Affairs Doug Plessinger, RPh Vice President, Clinical and Medical Affairs Doug Plessinger joined Argos Therapeutics in 2011 after serving as a clinical consultant for the company for the previous 4 years. Prior to joining Argos, Mr. Plessinger was an original founder and served as the Executive Vice President and Managing Director for Axcelo MSL Solutions, a Medical Affairs and MSL consulting company. Prior to this, he served as Senior Vice President of Client Services at The Navicor Group and in other roles with Navicor and affiliated inVentiv Health companies from 2003 to 2007. Mr. Plessinger also served as a lead Medical Science Liaison (MSL) for Millennium Pharmaceuticals and held various roles of increasing responsibility for Bristol-Myers Squibb in Oncology Medical Affairs and Oncology Global Marketing from 1997 - 2003. Overall, he has more than 20 years of clinical pharmacy, pharmaceutical, and client-services related experience, including the development and launch of multiple oncology products across various solid and hematologic malignancies. Mr. Plessinger holds a B.S. degree in Pharmacy and graduated summa cum laude from Northeastern University.


Press Releases - Argos Therapeutics

DURHAM, N.C., March 17, 2014 (GLOBE NEWSWIRE) -- Argos Therapeutics Inc. (Nasdaq:ARGS), a biopharmaceutical company focused on the development and commercialization of fully personalized immunotherapies for the treatment of cancer and infectious diseases using its Arcelis™ technology platform, today announced that Doug Plessinger, vice presid...


Similar Profiles

city

Browse ZoomInfo's Business
Contact Directory by City

city

Browse ZoomInfo's
Business People Directory

city

Browse ZoomInfo's
Advanced Company Directory